Asmahan Abu-Arish

Title: Innovations by Asmahan Abu-Arish

Introduction

Asmahan Abu-Arish is a notable inventor based in Verdun, Canada. She has made significant contributions to the field of biotechnology, particularly in enhancing ion transporter activity. Her work is crucial for developing treatments for channelopathies, which are disorders caused by dysfunctional ion channels.

Latest Patents

Asmahan holds a patent titled "Compositions and methods for enhancing ion transporter activity and uses thereof." This patent describes methods for enhancing the activity of an ion transporter in a cell and treating a channelopathy in a subject. The methods involve administering an effective amount of a fenretinide compound or zinc to restore or increase the cell surface expression of ion transporters, such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). The patent highlights the potential of combining fenretinide compounds with ion transporter modulators to further enhance the expression and activity of these transporters.

Career Highlights

Asmahan Abu-Arish is affiliated with McGill University, where she conducts her research and development work. Her innovative approaches have positioned her as a key figure in her field, contributing to advancements in medical treatments for genetic disorders.

Collaborations

Asmahan collaborates with esteemed colleagues, including Danuta Radzioch and John Hanrahan. These partnerships enhance her research efforts and contribute to the broader scientific community.

Conclusion

Asmahan Abu-Arish's work exemplifies the impact of innovation in biotechnology. Her patent and research efforts are paving the way for new treatments for channelopathies, showcasing her dedication to improving health outcomes.